BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Singh G, Yoshida EM, Rathi S, Marquez V, Kim P, Erb SR, Salh BS. Biomarkers for hepatocellular cancer. World J Hepatol 2020; 12(9): 558-573 [PMID: 33033565 DOI: 10.4254/wjh.v12.i9.558]
URL: https://www.wjgnet.com/1007-9327/full/v12/i9/558.htm
Number Citing Articles
1
Dongxu Zhao, Jian Cao, Lei Zhang, Shaohua Zhang, Song Wu. Targeted Molecular Imaging Probes Based on Magnetic Resonance Imaging for Hepatocellular Carcinoma Diagnosis and TreatmentBiosensors 2022; 12(5): 342 doi: 10.3390/bios12050342
2
Soo Young Jun, Hyang Ran Yoon, Ji-Yong Yoon, Su-Jin Jeon, Jeong-Ju Lee, Debasish Halder, Jin-Man Kim, Nam-Soon Kim. The Human TOR Signaling Regulator Is the Key Indicator of Liver Cancer Patients’ Overall Survival: TIPRL/LC3/CD133/CD44 as Potential Biomarkers for Early Liver CancersCancers 2021; 13(12): 2925 doi: 10.3390/cancers13122925
3
Ishfaq Hassan Mir, K. C. Jyothi, Chinnasamy Thirunavukkarasu. The prominence of potential biomarkers in the diagnosis and management of hepatocellular carcinoma: Current scenario and future anticipationJournal of Cellular Biochemistry 2021;  doi: 10.1002/jcb.30190
4
Luis M. Ruiz-Manriquez, Oscar Carrasco-Morales, E. Adrian Sanchez Z, Sofía Madeline Osorio-Perez, Carolina Estrada-Meza, Surajit Pathak, Antara Banerjee, Anindya Bandyopadhyay, Asim K. Duttaroy, Sujay Paul. MicroRNA-mediated regulation of key signaling pathways in hepatocellular carcinoma: A mechanistic insightFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.910733
5
Jiarong Li, Nianfeng Li, Muhammad Salman Azhar, Ling Liu, Liheng Wang, Qi Zhang, Langqing Sheng, Jianhua Wang, Sijia Feng, Qixuan Qiu, Yao Xiao. Analysis of mutations in DNA damage repair pathway gene in Chinese patients with hepatocellular carcinomaScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-16604-6
6
S Pilar Zamora-León. Hepatocellular carcinoma biomarkers, an imminent needWorld Journal of Gastrointestinal Oncology 2021; 13(11): 1847-1849 doi: 10.4251/wjgo.v13.i11.1847
7
Jessica Evangelista, Elisa Zaninotto, Annalisa Gaglio, Michele Ghidini, Lucrezia Raimondi. MicroRNAs as Diagnostic Tools in Hepatocellular CarcinomaGastrointestinal Disorders 2021; 3(4): 237 doi: 10.3390/gidisord3040022
8
Matteo Canale, Francesco Giuseppe Foschi, Pietro Andreone, Giorgio Ercolani, Giorgia Marisi, Fabio Conti, Ranka Vukotic, Valeria Guarneri, Valentina Burgio, Francesca Ratti, Luca Aldrighetti, Francesco De Cobelli, Stefano Cascinu, Paola Ulivi, Andrea Casadei-Gardini. Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgeryHPB 2022; 24(2): 244 doi: 10.1016/j.hpb.2021.06.421
9
Xiaoyue Ren, Alex Li, Edward Ying, Jhin Fang, Mingzhu Li, Jiao Yu. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progressionBioengineered 2021; 12(1): 1530 doi: 10.1080/21655979.2021.1918507
10
Yunxi Liu, Yue Chen, Weidong Fei, Caihong Zheng, Yongquan Zheng, Miao Tang, Ying Qian, Xiao Zhang, Mengdan Zhao, Meng Zhang, Fengmei Wang. Silica-Based Nanoframeworks Involved Hepatocellular Carcinoma TheranosticFrontiers in Bioengineering and Biotechnology 2021; 9 doi: 10.3389/fbioe.2021.733792
11
Gauhar Rehman. Cancer Biomarkers in Diagnosis and Therapeutics2022; : 65 doi: 10.1007/978-981-16-5759-7_3
12
Wojciech Książek, Filip Turza, Paweł Pławiak. NCA‐GA‐SVM: A new two‐level feature selection method based on neighborhood component analysis and genetic algorithm in hepatocellular carcinoma fatality prognosisInternational Journal for Numerical Methods in Biomedical Engineering 2022; 38(6) doi: 10.1002/cnm.3599
13
Cyriac A Philips, Sasidharan Rajesh, Dinu C Nair, Rizwan Ahamed, Jinsha K Abduljaleel, Philip Augustine. Hepatocellular Carcinoma in 2021: An Exhaustive UpdateCureus 2021;  doi: 10.7759/cureus.19274